Biotech Startup Mekonos raises oversubscribed $25 million round to overcome pharma industry’s cell & gene therapy delivery hurdles

SAN FRANCISCO: SAN FRANCISCO, Nov. 9, 2021 /PRNewswire/ -- Mekonos, a biotech company building the future of cell therapies on a chip, has raised $25M in an oversubscribed Series A round co-led by Reimagined Ventures, Fiscus Ventures, and PEAK6 Strategic Capital, a division of PEAK6 Investments. New institutional and strategic...

Click to view original post